Free Trial
TSE:TH

Theratechnologies 7/10/2024 Earnings Report

Theratechnologies logo
C$3.25 -0.03 (-0.91%)
As of 06/30/2025 03:59 PM Eastern

Theratechnologies EPS Results

Actual EPS
C$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Theratechnologies Revenue Results

Actual Revenue
$30.00 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Theratechnologies Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Theratechnologies Earnings Headlines

Theratechnologies Inc. (TH.TO)
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Soleus Capital issues letter to board of Theratechnologies
Theratechnologies upgraded to Buy from Hold at JonesResearch
See More Theratechnologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Theratechnologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Theratechnologies and other key companies, straight to your email.

About Theratechnologies

Theratechnologies (TSE:TH) Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

View Theratechnologies Profile

More Earnings Resources from MarketBeat